Paula-Lima AC, Tricerri MA, Brito-Moreira J, et al.: Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. In: Int. J. Biochem. Cell Biol. 41. Jahrgang, Nr.6, Juni 2009, S.1361–1370, doi:10.1016/j.biocel.2008.12.003, PMID 19130896.
Feng Y, Van Craeyveld E, Jacobs F, Lievens J, Snoeys J, De Geest B: Wild-type apo A-I and apo A-I(Milano) gene transfer reduce native and transplant arteriosclerosis to a similar extent. In: J Mol Med. 87. Jahrgang, Nr.3, März 2009, S.287–97, doi:10.1007/s00109-008-0427-y, PMID 19066833.
Bakillah A: Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects. In: Clin. Chem. Lab. Med. 47. Jahrgang, Nr.1, 2009, S.60–9, doi:10.1515/CCLM.2009.017, PMID 19055467.
nih.gov
ncbi.nlm.nih.gov
Mendez AJ.: The promise of apolipoprotein A-I mimetics. In: Curr Opin Endocrinol Diabetes Obes. 17. Jahrgang, Nr.2, April 2010, S.171–176, PMID 20125002.
Paula-Lima AC, Tricerri MA, Brito-Moreira J, et al.: Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. In: Int. J. Biochem. Cell Biol. 41. Jahrgang, Nr.6, Juni 2009, S.1361–1370, doi:10.1016/j.biocel.2008.12.003, PMID 19130896.
Feng Y, Van Craeyveld E, Jacobs F, Lievens J, Snoeys J, De Geest B: Wild-type apo A-I and apo A-I(Milano) gene transfer reduce native and transplant arteriosclerosis to a similar extent. In: J Mol Med. 87. Jahrgang, Nr.3, März 2009, S.287–97, doi:10.1007/s00109-008-0427-y, PMID 19066833.
Bakillah A: Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects. In: Clin. Chem. Lab. Med. 47. Jahrgang, Nr.1, 2009, S.60–9, doi:10.1515/CCLM.2009.017, PMID 19055467.
